ASX - By Stock
|
OSL |
Re:
Ann: Australian institution to invest $2.7 million in OSL
|
|
maxswell
|
32 |
7.8K |
4 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
32
|
7.8K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
maxswell
|
25K |
12M |
5 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
25K
|
12M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
maxswell
|
25K |
12M |
6 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
25K
|
12M
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
maxswell
|
26 |
6.9K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
26
|
6.9K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
maxswell
|
14K |
7.0M |
65 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
14K
|
7.0M
|
65
|
|
ASX - By Stock
|
ACW |
Re:
Ann: First site activated in ACW XanaMIA Phase 2b AD trial
|
|
maxswell
|
12 |
7.0K |
1 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
12
|
7.0K
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
maxswell
|
33K |
16M |
5 |
15/11/23 |
15/11/23 |
Charts
|
33K
|
16M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
maxswell
|
10K |
5.0M |
3 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
10K
|
5.0M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q2 2023 quarterly activity and cash flow report
|
|
maxswell
|
73 |
31K |
19 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
73
|
31K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Letter to Shareholders
|
|
maxswell
|
240 |
107K |
3 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
240
|
107K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
maxswell
|
14K |
7.0M |
2 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
14K
|
7.0M
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Share purchase plan (SPP) - closing date extended
|
|
maxswell
|
20 |
7.5K |
6 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
20
|
7.5K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Mr Otto Buttula to Retire from the Board
|
|
maxswell
|
34 |
14K |
0 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
34
|
14K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
maxswell
|
7 |
2.7K |
6 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
7
|
2.7K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
NEU
|
|
maxswell
|
12 |
8.9K |
1 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
12
|
8.9K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
NEU
|
|
maxswell
|
12 |
8.9K |
2 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
12
|
8.9K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Presentation to the JP Morgan Healthcare Conference
|
|
maxswell
|
50 |
30K |
22 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
50
|
30K
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
maxswell
|
14K |
7.0M |
15 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
14K
|
7.0M
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
maxswell
|
14K |
7.0M |
2 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
14K
|
7.0M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
maxswell
|
255 |
158K |
8 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
255
|
158K
|
8
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
maxswell
|
33K |
16M |
4 |
21/07/22 |
21/07/22 |
Charts
|
33K
|
16M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
maxswell
|
14K |
7.0M |
11 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
14K
|
7.0M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
maxswell
|
14K |
7.0M |
7 |
06/07/22 |
06/07/22 |
ASX - By Stock
|
14K
|
7.0M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results
|
|
maxswell
|
439 |
229K |
12 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
439
|
229K
|
12
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results
|
|
maxswell
|
439 |
229K |
42 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
439
|
229K
|
42
|
|
ASX - By Stock
|
ID8 |
Re:
Ann: Rabobank Signs Five Year Licence Agreement
|
|
maxswell
|
32 |
10K |
4 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
32
|
10K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Short Position
|
|
maxswell
|
189 |
87K |
6 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
189
|
87K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
maxswell
|
14K |
7.0M |
34 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
14K
|
7.0M
|
34
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clarification Announcement
|
|
maxswell
|
407 |
166K |
6 |
04/05/22 |
04/05/22 |
ASX - By Stock
|
407
|
166K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clarification Announcement
|
|
maxswell
|
407 |
166K |
0 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
407
|
166K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Termination of Supply Agreement
|
|
maxswell
|
448 |
254K |
5 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
448
|
254K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
maxswell
|
14K |
7.0M |
0 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
14K
|
7.0M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
maxswell
|
14K |
7.0M |
13 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
14K
|
7.0M
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
maxswell
|
10K |
5.0M |
18 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
10K
|
5.0M
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Investor Presentation
|
|
maxswell
|
185 |
87K |
14 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
185
|
87K
|
14
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Chimeric Therapeutics CDH17 Investor Webinar
|
|
maxswell
|
7 |
3.1K |
6 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
7
|
3.1K
|
6
|
|
ASX - By Stock
|
TI1 |
Re:
Ann: Maiden Shipment of High Grade Lump Departs
|
|
maxswell
|
53 |
14K |
5 |
23/07/21 |
23/07/21 |
ASX - By Stock
|
53
|
14K
|
5
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
maxswell
|
33K |
16M |
1 |
03/07/21 |
03/07/21 |
Charts
|
33K
|
16M
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
maxswell
|
33K |
16M |
4 |
03/07/21 |
03/07/21 |
Charts
|
33K
|
16M
|
4
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
maxswell
|
33K |
16M |
34 |
03/07/21 |
03/07/21 |
Charts
|
33K
|
16M
|
34
|
|
ASX - By Stock
|
IMU |
Re:
CF 33 General Discussion
|
|
maxswell
|
49 |
23K |
8 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
49
|
23K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC
|
|
maxswell
|
246 |
137K |
33 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
246
|
137K
|
33
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA IND APPROVAL OF NEW ONCOLYTIC VIROTHERAPY CHECKVACC
|
|
maxswell
|
246 |
137K |
25 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
246
|
137K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
CF 33 General Discussion
|
|
maxswell
|
49 |
23K |
21 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
49
|
23K
|
21
|
|
ASX - By Stock
|
PTX |
Re:
sp should be 5x imho
|
|
maxswell
|
1.0K |
394K |
9 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
1.0K
|
394K
|
9
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Valuation Model Indicative Price $1.33
|
|
maxswell
|
122 |
75K |
18 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
122
|
75K
|
18
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
maxswell
|
33K |
16M |
16 |
27/05/21 |
27/05/21 |
Charts
|
33K
|
16M
|
16
|
|
ASX - By Stock
|
IMU |
Re:
Ann: CEO & Executive Chairman increases IMU shareholding
|
|
maxswell
|
118 |
51K |
4 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
118
|
51K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: CEO & Executive Chairman increases IMU shareholding
|
|
maxswell
|
118 |
51K |
10 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
118
|
51K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: CEO & Executive Chairman increases IMU shareholding
|
|
maxswell
|
118 |
51K |
9 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
118
|
51K
|
9
|
|